Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a small update to the page's metadata.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page now shows a new Revision: v3.6.2 tag, replacing Revision: v3.6.0, indicating a minor template update for the page.SummaryDifference0.0%

- Check38 days agoChange DetectedRecruitment status on the study page is updated to 'No longer looking for participants', and several help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The label Interventions formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment', and the Revision/version indicator was updated from v3.5.5 to v3.6.0.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision label v3.5.5 was added to the page's revision history, and the previous label v3.5.4 was removed. This indicates the page content has been updated to a newer version.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page’s revision history. The change does not modify content or user-facing features.SummaryDifference0.0%

- Check73 days agoChange DetectedUpdated the study location entry to Malmö, Sweden, SE-205 02. The previous listing Malmo, Sweden, SE-205 02 was replaced to reflect the correct spelling.SummaryDifference0.0%

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.